COVID-19 pandemic in the Sahrawi Arab Democratic Republic
The COVID-19 pandemic in the Sahrawi Arab Democratic Republic refers to the ongoing global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the Sahrawi Arab Democratic Republic (SADR). The first case of COVID-19 in the SADR was confirmed in April 2020.
Background[edit | edit source]
The Sahrawi Arab Democratic Republic, a partially recognized state that claims sovereignty over the entire territory of Western Sahara, has limited international recognition and resources. The region's healthcare infrastructure is underdeveloped, primarily relying on support from international organizations.
Timeline[edit | edit source]
2020[edit | edit source]
In April 2020, the first case of COVID-19 was reported in the Sahrawi refugee camps near Tindouf, Algeria. The government and the Polisario Front, the governing body of the SADR, implemented measures to control the spread of the virus, including travel restrictions and public health campaigns.
2021[edit | edit source]
Throughout 2021, the SADR continued to face challenges in managing the spread of COVID-19 due to limited access to vaccines and medical supplies. Efforts were made to secure vaccines through collaborations with international partners.
Impact[edit | edit source]
Health[edit | edit source]
The impact on the health of the population has been significant, with multiple cases leading to severe health outcomes and strain on the healthcare system.
Economic[edit | edit source]
The pandemic has also affected the economy of the SADR, which is largely dependent on aid and the local market. Restrictions on movement and trade have further strained the economic stability of the region.
Social[edit | edit source]
Socially, the pandemic has led to changes in daily life, with educational institutions and public gatherings affected. The traditional nomadic lifestyle of some Sahrawi people has also been impacted.
Response[edit | edit source]
The response to the pandemic in the SADR has involved coordination with Algeria, non-governmental organizations, and international health organizations to provide testing, treatment, and vaccination efforts.
See also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
